<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1538973079464292&amp;ev=PageView&amp;noscript=1">
MENU
Search

What are you looking for?

    Tafenoquine and Atovaquone Combo Shows Promise in Babesiosis Treatment
    January 5, 2024

    Learn about a breakthrough in the treatment of babesiosis using a combination of tafenoquine and atovaquone. This innovative approach shows potential for complete cure and immune protection, according...

    What is Rapid or Point-Of-Care Testing for Lyme Disease?
    October 18, 2023

    By Jane M. Caldwell, Ph.D. – Executive Director, Medavera Inc., Springfield, MO and Elizabeth Lee-Lewandrowski, Ph.D., MPH - Assistant Professor, Harvard Medical School, Department of Pathology, Massa...

    American Society for Microbiology Publishes Minireview, Research Funded by GLA
    May 14, 2022

    American Society for Microbiology (ASM) has over 30,000 members, including researchers, educators, and health professionals. ASM is one of the largest life science societies in the world. The minirevi...

    Lyme Disease and Bell’s Palsy: New Considerations for Differential Diagnosis
    March 28, 2022

    Promising New Lyme Disease Antibiotic May Spare Microbiome
    October 6, 2021

    An exciting new finding by. Dr. Kim Lewis of Northeastern University gives hope that Lyme disease can be potentially treated without harming the microbiome Why is antibiotic treatment for Lyme disease...

    Tafenoquine and Atovaquone Combo Shows Promise in Babesiosis Treatment
    What is Rapid or Point-Of-Care Testing for Lyme Disease?
    American Society for Microbiology Publishes Minireview, Research Funded by GLA
    Lyme Disease and Bell’s Palsy: New Considerations for Differential Diagnosis
    Promising New Lyme Disease Antibiotic May Spare Microbiome

    Science and Research posts

    Tafenoquine and Atovaquone Combo Shows Promise in Babesiosis Treatment
    January 5, 2024
    Learn about a breakthrough in the treatment of babesiosis using a combination of tafenoquine and atovaquone. This innovative approach shows potential for complete cure and immune protection, according to recent research. The current treatments for babesiosis can come with severe side effects, the ri...
    Read More
    What is Rapid or Point-Of-Care Testing for Lyme Disease?
    October 18, 2023
    By Jane M. Caldwell, Ph.D. – Executive Director, Medavera Inc., Springfield, MO and Elizabeth Lee-Lewandrowski, Ph.D., MPH - Assistant Professor, Harvard Medical School, Department of Pathology, Massachusetts General Hospital, Boston
    Read More
    American Society for Microbiology Publishes Minireview, Research Funded by GLA
    May 14, 2022
    American Society for Microbiology (ASM) has over 30,000 members, including researchers, educators, and health professionals. ASM is one of the largest life science societies in the world. The minireview covers "Borreliella burgdorferi Antimicrobial-Tolerant Persistence in Lyme Disease and Posttreatm...
    Read More
    Lyme Disease and Bell’s Palsy: New Considerations for Differential Diagnosis
    March 28, 2022
    Read More
    Promising New Lyme Disease Antibiotic May Spare Microbiome
    October 6, 2021
    An exciting new finding by. Dr. Kim Lewis of Northeastern University gives hope that Lyme disease can be potentially treated without harming the microbiome Why is antibiotic treatment for Lyme disease often problematic? A significant side effect of treating Lyme disease is the disruption of the gut ...
    Read More
    Lyme Disease and Mental Disorders: It’s Not All in Your Head
    July 29, 2021
    A recent study in Denmark funded by Global Lyme Alliance analyzes patient data associated with Lyme disease and the impact it has on mental health Mental disorders are among the most poorly understood symptoms of Lyme disease. Early on, it was recognized that Lyme disease in late stages includes neu...
    Read More
    Meet the Researcher: Michael Eriksen Benros, M.D., Ph.D.
    July 25, 2021
    Michael Eriksen Benros, M.D., Ph.D. is professor and Head of Research at Mental Health Centre Copenhagen, Copenhagen University Hospital, Denmark. He received a two year grant from GLA for his study: Nationwide Cohort Studies Examining Psychiatric Disorders and Suicidal Behavior after Lyme disease.
    Read More
    Meet the Researcher: Shannon Delaney, M.D.
    July 8, 2021
    Shannon Delaney, M.D., is Director of Child and Adolescent Evaluation at the Lyme & Tick-borne Diseases Research Center, and Assistant Professor, Columbia University Vagelos College of Physicians and Surgeons. She is an expert in child and adult neuropsychiatry and infection-triggered neuropsych...
    Read More
    Borrelia miyamotoi: Hiding in Plain Sight?
    May 22, 2021
    GLA's Director of Research and Science, Dr. Mayla Hsu, discusses findings by Dr. Shannon Delaney, who suggests that Borrelia miyamotoi is an infectious trigger for chronic illness, closely resembling Lyme disease. What do we know about chronic illness following a Lyme disease diagnosis? We know that...
    Read More
    Meet the Researcher - George Aranjuez Ph.D.
    March 29, 2021
    George Aranjuez, Ph.D. is faculty research associate at University of Central Florida. His postdoctoral research was supported by a Deborah and Mark Blackman-GLA fellowship award. His most recent peer-reviewed articles, about the replication of Borrelia burgdorferi, appear here and here. Why did you...
    Read More
    Dendritic Cells: A Possible Pathway to Lyme Autoimmunity?
    February 16, 2021
    In the Covid-19 pandemic era, survival and recovery are on our minds. It’s become recognized that some patients recover quickly from Covid-19, but others may take months or possibly longer to feel better. Sound familiar? The Lyme disease community has a long experience with lingering, debilitating s...
    Read More
    Meet the Researcher: Maria Gutierrez-Hoffmann, Ph.D.
    February 16, 2021
    Maria Gutierrez-Hoffmann, Ph.D. is a scientist at the Food and Drug Administration in the Office of Pharmaceutical Manufacturing Assessment. As a postdoctoral fellow, her Lyme disease research was supported by GLA. Her most recent peer-reviewed publication is Borrelia burgdorferi-Induced Changes in ...
    Read More
    Lyme Disease Incidence: Even Greater Than Thought
    February 5, 2021
    POV by Timothy J. Sellati, Ph.D., Chief Scientific Officer, GLA How many people get Lyme disease every year? Precisely determining an annual incidence has been a challenge. Based upon a surveillance rather than a clinical definition, there is an ongoing discrepancy between Lyme disease cases reporte...
    Read More
    Meet the Researcher: Lise Nigrovic, M.D., M.P.H.
    January 6, 2021
    Meet the Researcher is a blog series to introduce GLA-funded Lyme disease researchers. Lise Nigrovic, M.D., M.P.H. is Associate Professor of Pediatrics and Emergency Medicine at Boston Children’s Hospital and Harvard Medical School in Boston, Massachusetts, USA.
    Read More
    An Innovative Approach To Understanding Pediatric Lyme Disease
    December 28, 2020
    by Mayla Hsu, Ph.D., Director of Research and Science, GLA
    Read More
    How Our Body ‘Sees’ Spirochetes Has Implications for Lyme Disease Severity and Novel Treatments
    December 20, 2020
    by Timothy J. Sellati, Ph.D., Chief Scientific Officer, GLA
    Read More
    The Similarities Between Post-COVID-19 and Lyme Disease
    November 17, 2020
    Tens of thousands of people in the U.S. have lingering illness following COVID-19, known as post-Covid “long haulers.” Why do some people recover relatively quickly from Lyme disease and Covid-19, and a significant number do not? by Mayla Hsu, Ph.D., Director of Research and Science, GLA
    Read More
    When Interpretation of Results Misses the Bull’s-eye
    November 14, 2020
    by Timothy J. Sellati, Ph.D., Chief Scientific Officer, GLA
    Read More
    Lyme Arthritis and Inflammation: Shut It Off!
    September 23, 2020
    A summary of 3 Lyme arthritis studies and how our immune system can fail to shut off when there’s an infection. by Mayla Hsu, Ph.D., Director of Research and Science, GLA
    Read More
    The need for an alternative to current antibody-based Lyme disease diagnostic tests
    August 25, 2020
    by Timothy J. Sellati, Ph.D., Chief Scientific Officer, Global Lyme Alliance
    Read More
    VIEW MORE

    We need some information
    GLA
    Global Lyme Alliance
    PO Box 25495
    New York, NY 10087-5495

    2023 © Copyright Global Lyme Alliance. All rights reserved.

    Disclaimer: The above material is provided for information purposes only. The material (a) is not nor should be considered, or used as a substitute for, medical advice, diagnosis, or treatment, nor (b) does it necessarily represent endorsement by or an official position of Global Lyme Alliance, Inc. or any of its directors, officers, advisors or volunteers. Advice on the testing, treatment or care of an individual patient should be obtained through consultation with a physician who has examined that patient or is familiar with that patient’s medical history. Global Lyme Alliance, Inc. makes no warranties of any kind regarding this Website, including as to the accuracy, completeness, currency or reliability of any information contained herein, and all such warranties are expressly disclaimed.